Drug intelligence / Profile preview

K-rhein

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

K-rhein is a tri-potassium salt of rhein, an anthraquinone compound derived from various medicinal herbs such as *Rheum palmatum L.* and *Aloe barbadensis Miller*. It was developed to enhance the poor water solubility of its active component, rhein. K-rhein specifically functions as an inhibitor of CD38 enzymatic activity. Rhein, the active ingredient, exhibits a broad spectrum of pharmacological activities, including anti-inflammatory, anticancer, antidiabetic, hepatoprotective, nephroprotective, antioxidant, and antifibrotic effects. Its mechanism involves modulating various signaling pathways such as NF-κB, PI3K/Akt, MAPK, p53, and HIF-1, and it can induce apoptosis in cancer cells. K-rhein has demonstrated potential in inhibiting glioma progression.

Other names
Tri-potassium salt of rhein
02

Targets

HSP90 (Heat shock protein 90 chaperone complex)LXRB (Liver X receptor beta)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)HIF1A (Hypoxia-inducible factor 1-alpha)ERBB2 (Erb-b2 receptor tyrosine kinase 2)NR1H3 (Liver X receptor beta)DNAMMP2 (Matrix metalloproteinase-2)

Beyond the preview

Go deeper on K-rhein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on K-rhein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call